SciELO - Scientific Electronic Library Online

 
vol.41 issue2Airway rescue in the prone position with laryngeal mask airway in a case of lumbar spinal stenosis undergoing percutaneous posterior decompression using an inter-spinous spacer devicePulmonary embolectomy and cardiopulmonary bypass during pregnancy author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Colombian Journal of Anestesiology

Print version ISSN 0120-3347

Abstract

MOHINDER SINGH, Preet  and  TRIKHA, Anjan. Two cases of refractory writer's cramp in pain clinic: Is botulinum the answer?. Rev. colomb. anestesiol. [online]. 2013, vol.41, n.2, pp.161-165. ISSN 0120-3347.  https://doi.org/10.1016/j.rca.2012.12.004.

Introduction: Writer’s cramp is a refractory painful disorder, often presenting as a disabling disease while writing for a short duration. The conventional therapy in the form of neurogenic agents such as carbamazepine often fails to benefit these patients. Modern literature has highlighted the used of botulinum toxin in focal dystonisas and hence its use can also be extrapolated in patients of writer’s cramps. Aim: Evaluating the efficacy and safety of botulinum toxin in refractory writer’s cramps. Methodology:We present 2 cases of diagnosed refractory writer’s cramp. These patients were evaluated for group of handmuscles involved. Once themuscles were identified, botulinum toxin was injected into these muscles and clinical response was used to iterate the total dose of botulinum needed. These patients were followed up for degree of relief and any associated adverse effects. Results: Both patients showed significant clinical relief after the use of botulinum toxin. Their writing time improved and both patients reported a significant pain relief. The patients required repeat injection 3-6 months, however with each reoccurrence their ailment decreased and they could be taken off oral medication. Minor clinically insignificant reversible weakness was seen in one patient, which reverted to normal in 2-3 weeks time which did not affect patients’ satisfaction to treatment, as the primary disease was disabling for daily professional work. Conclusion: Botulinum toxin is a safe and effective therapeutic option for treating patients of refractory writer’s cramp presenting in the pain clinic.

Keywords : Botulinum for focal dystonia; Writer’s cramp; Botulinum in pain clinic.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )